Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues

Immunobiology

Volumn 218, Issue 7, 2013, Pages 1012-1017

  Stefani, Florença Abdanur ^a   Viana, Michelle Beatriz ^a   Dupim, Ana Carolina ^a   Brito, João Artur Ricieri ^a   Gomez, Ricardo Santiago ^a   Da Costa, José Eustáquio ^a   Moreira, Paula Rocha ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Gene expression; Interleukin 6; Methylation; Periodontitis; Polymorphism

Indexed keywords

INTERLEUKIN 6; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; GINGIVAL BIOPSY; HUMAN; HUMAN TISSUE; IL6 GENE; IMMUNE RESPONSE; MALE; NUCLEOTIDE SEQUENCE; PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN POLYMORPHISM; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; GINGIVA; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84877150385     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.12.001     Document Type: Article

References (52)

1. Addock I.M., Maneechotesuwwan K., Usmani O. Molecular interactions between glucocorticoids and long-acting beta2-agonist. J. Allergy Clin. Immunol. 2002, 110(Suppl.):261-268.
2. Albandar J.M. Global risk factors and risk indicators for periodontal diseases. Periodontology 2000 2002, 29:177-206.
3. Andia D.C., de Oliveira N.F., Casarin R.C., Casati M.Z., Line S.R., de Souza A.P. DNA methylation status of the IL-8 gene promoter in aggressive periodontitis. J. Periodontol. 2010, 81:1336-1341.
4. Armenante F., Merola M., Furia A., Palmiere M. Repression of the IL-6 gene is associated with hypermethylation. Biochem. Biophys. Res. Commun. 1999, 258:644-647.
5. Armitage G.C. Peridontal disease: diagnosis. Ann. Periodontol. 1996, 1:37-215.
6. Armitage G.C. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 1999, 4:1-6.
7. Barros S.P., Wirojchanasak S., Barrow D.A., et al. Triclosan inhibition of acute and chronic inflammatory gene pathways. J. Clin. Periodontol. 2010, 37:412-418.
8. Batista A.C., Silva T.S., Chun J.H., Lara V.S. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis. 2002, 8:254-260.
9. Brakensiek K., Länger F., Kreipe H., Lehmann U. Absence of p21 (C1P1), p27 (KIP 1) and p57 (KIP2) methylation in MDS and AML. Leuk. Res. 2005, 29:1357-1360.
10. Egger G., Liang G., Aparicio A., Jones P.A. Epigenetic in human disease and prospects for epigenetic therapy. Nature 2004, 429:457-463.
11. Feinberg A.P. Epigenetics at the epicenter of modern medicine. JAMA 2008, 299:1345-1350.
12. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
13. Fitzpatrick D.R., Wilson C.B. Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin. Immunol. 2003, 109:37-45.
14. Flemming T.F. Periodontites. Ann. Periodontol. 1999, 4:32-37.
15. Geivelis M., Turner D.W., Pederson E.D., Lamberts B.L. Measurements of interleukin-6 in crevicular fluid from adults with destructive periodontal disease. J. Periodontol. 1993, 64:980-983.
16. Gemmell E., Marshall R.I., Seymour G.J. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontology 2000 1997, 14:112-143.
17. Gemmell E., Seymour G.J. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontology 2000 2004, 35:21-41.
18. Goldenberg D., Harden S., Masayesva B.G., et al. Intraoperative molecular margin analysis in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 2004, 130:39-44.
19. Gomez R.S., Dutra W.O., Moreira P.R. Epigenetics and periodontal disease: future perspectives. Inflamm. Res. 2009, 58:625-629.
20. Holla L.I., Buckova D., Fassmann A., Halabala T., Vasku A., Vacha J. Promoter polymorphisms in the CD 14 receptor gene and their potential association with the severity of chronic periodontitis. J. Med. Genet. 2002, 39:844-848.
21. Irwin C.R., Myrillas T.T. The role of IL-6 in the pathogenesis of periodontal disease. Oral dis. 1998, 4:43-47.
22. Irwin C.R., Myrillas T.T., Traynor P., Leadbetter N., Cawston T.E. The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts. J. Periodontal. 2002, 73:741-747.
23. Ishida K., Kobayashi T., Ito S., Komatsu Y., Yokoyama T., Okada M., Abe A., Murasawa A., Yoshie H. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol 2012, 83(7):917-925.
24. Kinane D.F., Hart T.C. Genes and gene polymorphisms associated with periodontal disease. Crit. Rev. Oral Biol. Med. 2003, 14:430-449.
25. Kishi M., Nakamura M., Nishimine M., Ikuta M., Kirita T., Konish N. Genetic and epigenetic alteration profiles for multiple genes in salivary and carcinoma. Oral Oncol. 2005, 41:161-169.
26. Klein W., Tromm A., Griga T., et al. The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 2001, 13:45-47.
27. Kornman K.S., Page R.C., Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology 2000 1997, 14:33-53.
28. Kwong J., Lo K.W., Chow L.S., Chan F.L., To K.F., Huang D.P. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int. J. Cancer 2005, 113:386-392.
29. Lee H.J., Kang I.K., Chung C.P., Choi S.M. The subgengival microflora and gingival fluid cytokines in refractory periodontites. J. Clin. Periodontol. 1995, 22:885-890.
30. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
31. López N.J., Smith P.C., Gutierrez J. Periodontal therapy may reduce the risk of preterm low birth weight in women with periodontal disease: a randomized controlled trial. J. Periodontol. 2002, 73:911-924.
32. Mercado F.B., Marshall R.I., Bartold P.M. Inter-relationships between rheumatoid arthritis and periodontal diseases. J. Clin. Periodontol. 2003, 30:761-772.
33. Mi X.B., Zeng F.Q. Hypomethylation of interleukin-4 and -6 in T cells from systemic lupus erythematosus patients. Acta Pharmacol. Sin. 2008, 29:105-112.
34. Moreira P.R., Lima P.M.A., Sathler K.O.B., et al. Interleukin-6 expression and gene polymorphism are associated with severity of periodontal disease in a sample of Brazilian individuals. Clin. Exp. Immunol. 2007, 148:119-129.
35. Nile C.J., Read R.C., Akil M., Duff G.W., Wilson A.G. Methylation status in a single Cpg site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 2008, 54:2686-2693.
36. Offenbacher S., Barros P.S., Beck J.D. Rethinking periodontal inflammation. J. Periodontol. 2008, 79(Suppl.):1577-1584.
37. Offenbacher S. Periodontal disease: pathogenesis. Ann. Periodontol. 1996, 1:821-878.
38. Oliveira N.F.P., Damm G.R., Andia D.C., Salmon C., Nociti F.H., Line S.R.P., de Souza A.P. DNA methylation status of the IL8 gene promoter in oral cells of smokers and non-smokers with chronic periodontitis. J. Clin. Periodontol. 2009, 36:719-725.
39. Page R.C., Kornman K.S. Pathogenesis of periodontitis: an introduction. Periodontology 2000 1997, 14:9-11.
40. Schekein H.A. Finding genetic risk factors for periodontal diseases: is the climb worth the view?. Periodontology 2000 2002, 30:79-90.
41. T method. Nat. Protoc. 2008, 3:1101-1108.
42. Shao M., Huang P., Cheng R., Hu T. Interleukin-6 polymorphisms modify the risk of periodontites: a systematic review and meta-analysis. J. Zhejiang Univ. Sci. B 2009, 920-927.
43. Shapira L., Wilensky A., Kinane D.F. Effect of genetic variability on the inflammatory response to periodontal infection. J. Clin. Periodontol. 2005, 32:72-86.
44. Sodek J., McKee M.D. Molecular and cellular biology of alveolar bone. Periodontology 2000 2000, 24:99-126.
45. Takahashi K., Takashiba S., Nagai A., et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease. J. Periodontol. 1994, 65:147-153.
46. Taylor J.J., Preshaw P.M., Donaldson P.T. Cytokine gene polymorphism and immunoregulation in periodontal disease. Periodontology 2000 2004, 35:158-182.
47. Tervonen T., Raunio T., knuuttila M., Karttunen R. Polymorphisms in the CD-4 and IL-6 genes associated with periodontal disease. J. Clin. Periodontol. 2007, 34:377-383.
48. Trevilatto P.C., Scarel-Caminaga R.M., de Brito R.B., de Souza A.P., Line S.R.P. Polymorphism at position -174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian population. J. Clin. Periodontol. 2003, 30:438-442.
49. Van Snick J. Interleukin-6: an overview. Annu. Rev. Immunol. 1990, 8:253-278.
50. Viana M.B., Cardoso F.P., Diniz M.G., Costa F.O., da Costa J.E., Gomez R.S., Moreira P.R. Methylation pattern of IFN-γ and IL-10 genes in periodontal tissues. Immunobiology 2011, 216:936-941.
51. Winders B.R., Schwartz R.H., Bruniquel D.A. A distinct region of the murine INF-γ promoter is hypomethylated from early T cell development through mature naive and Th1cell differentiation, but is hypermethylation in Th2 cells. J. Immunol. 2004, 173:7377-7384.
52. Zhang S., Crivello A., Offenbacher S., Moretti A., Paquette D.W., Barros S.P. Interferon-gamma promoter hypomethylation and increased expression in chronic periodontitis. J. Clin. Periodontol. 2010, 37:953-961.